Profound Medical (NASDAQ:PROF – Get Free Report) and Integrated BioPharma (OTCMKTS:INBP – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation.
Risk & Volatility
Profound Medical has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. Comparatively, Integrated BioPharma has a beta of 0.35, indicating that its stock price is 65% less volatile than the S&P 500.
Profitability
This table compares Profound Medical and Integrated BioPharma’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Profound Medical | -206.76% | -78.88% | -64.06% |
| Integrated BioPharma | -3.43% | -8.32% | -6.57% |
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Profound Medical | 1 | 0 | 1 | 0 | 2.00 |
| Integrated BioPharma | 0 | 0 | 0 | 0 | 0.00 |
Profound Medical currently has a consensus target price of $12.00, suggesting a potential upside of 74.67%. Given Profound Medical’s stronger consensus rating and higher possible upside, research analysts clearly believe Profound Medical is more favorable than Integrated BioPharma.
Earnings & Valuation
This table compares Profound Medical and Integrated BioPharma”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Profound Medical | $16.10 million | 15.51 | -$42.57 million | ($1.24) | -5.54 |
| Integrated BioPharma | $54.35 million | 0.11 | $810,000.00 | ($0.07) | -2.70 |
Integrated BioPharma has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Integrated BioPharma, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
47.9% of Profound Medical shares are held by institutional investors. Comparatively, 25.3% of Integrated BioPharma shares are held by institutional investors. 1.5% of Profound Medical shares are held by company insiders. Comparatively, 67.4% of Integrated BioPharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
Integrated BioPharma beats Profound Medical on 8 of the 14 factors compared between the two stocks.
About Profound Medical
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
About Integrated BioPharma
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Receive News & Ratings for Profound Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profound Medical and related companies with MarketBeat.com's FREE daily email newsletter.
